Genetics and Causality of Triglyceride-Rich Lipoproteins in Atherosclerotic Cardiovascular Disease

被引：204

作者：

Rosenson, Robert S. ^{[1
]}

Davidson, Michael H. ^{[2
]}

Hirsh, Benjamin J. ^{[3
]}

Kathiresan, Sekar ^{[4
]}

Gaudet, Daniel ^{[5
,6
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Univ Chicago, Pritzker Sch Med, Div Cardiol, Chicago, IL 60637 USA

[3] Mt Sinai Hosp, New York, NY 10029 USA

[4] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA

[5] Univ Montreal, Dept Med, ECOGENE 21, Chicoutimi, PQ, Canada

[6] Univ Montreal, Dept Med, Lipid Clin, Chicoutimi, PQ, Canada

来源：

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 64卷 / 23期

关键词：

atherosclerosis; cardiovascular disease; genetics; triglyceride; triglyceride-rich lipoproteins; LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; APOLIPOPROTEIN C-III; ALIPOGENE TIPARVOVEC AAV1-LPLS447X; TISSUE-SPECIFIC EXPRESSION; CYTOSOLIC LIPID DROPLETS; GENOME-WIDE ASSOCIATION; EXTENDED-RELEASE NIACIN; NONFASTING TRIGLYCERIDES; SEVERE HYPERTRIGLYCERIDEMIA;

D O I：

10.1016/j.jacc.2014.09.042

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Triglycerides represent 1 component of a heterogeneous pool of triglyceride-rich lipoproteins (TGRLs). The reliance on triglycerides or TGRLs as cardiovascular disease (CVD) risk biomarkers prompted investigations into therapies that lower plasma triglycerides as a means to reduce CVD events. Genetic studies identified TGRL components and pathways involved in their synthesis and metabolism. We advocate that only a subset of genetic mechanisms regulating TGRLs contribute to the risk of CVD events. This " omic" approach recently resulted in new targets for reducing CVD events. (C) 2014 by the American College of Cardiology Foundation.

引用

页码：2525 / 2540

页数：16

共 50 条

[41] Leukocyte activation by triglyceride-rich lipoproteins
Alipour, Arash
van Oostrom, Antonie J. H. H. M.
Izraeljan, Alisa
Verseyden, Caroline
Collins, Jennifer M.
Frayn, Keith N.
Plokker, Thijs W. M.
Elte, Jan Willem F.
Cabezas, Manuel Castro
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (04) : 792 - 797
[42] Intracellular metabolism of triglyceride-rich lipoproteins
Heeren, J
Beisiegel, U
CURRENT OPINION IN LIPIDOLOGY, 2001, 12 (03) : 255 - 260
[43] Triglyceride-rich lipoproteins and progression of atherosclerosis
Hodis, HN
Mack, WJ
EUROPEAN HEART JOURNAL, 1998, 19 : A40 - A44
[44] Cellular catabolism of triglyceride-rich lipoproteins
Heeren, J
Beisiegel, U
ATHEROSCLEROSIS XI, 1998, 1155 : 873 - 878
[45] TRIGLYCERIDE-RICH LIPOPROTEINS: THEIR ROLE IN ATHEROSCLEROSIS
Castillo-Nunez, Yulino
Morales-Villegas, Enrique
Aguilar-Salinas, Carlos A.
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2022, 74 (02): : 61 - 70
[46] Are triglyceride-rich lipoproteins directly proatherogenic?
Steinberg, D
ATHEROSCLEROSIS, 1998, 138 : S5 - S5
[47] LP(A) AND PLASMA TRIGLYCERIDE-RICH LIPOPROTEINS
MCCONATHY, WJ
TRIEU, VN
KLOR, HU
CORDER, CN
KLINISCHE WOCHENSCHRIFT, 1990, 68 : 117 - 119
[48] The significance of triglyceride-rich atherogenic lipoproteins in predicting future cardiovascular events
McHugh, Vicki L.
Mathiason, Michelle A.
Akosah, Kwame O.
CIRCULATION, 2007, 115 (08) : E263 - E264
[49] Association of triglyceride-rich lipoproteins and high density lipoproteins with coronary artery disease
Mokuno, H
Kurata, T
Watanabe, Y
Yamaguchi, H
Yamada, N
ATHEROSCLEROSIS, 1997, 134 (1-2) : 346 - 347
[50] TRIGLYCERIDE-RICH LIPOPROTEINS AND THE PROGRESSION OF CORONARY-ARTERY DISEASE
HODIS, HN
MACK, WJ
CURRENT OPINION IN LIPIDOLOGY, 1995, 6 (04) : 209 - 214

← 1 2 3 4 5 →